CHICAGO, April 8, 2024 /PRNewswire/ -- Sepsis Diagnostics Market in terms of revenue was estimated to be worth $634 million in 2024 and is poised to reach $890 million by 2029, growing at a CAGR of 7.0% from 2024 to 2029 according to a new report by MarketsandMarkets.
Factors such the commercialization and availability of a wide variety of approved sepsis diagnostic devices, rising prevalence of sepsis, incidence of hospital-acquired infections, growing number of surgical procedures and increasing geriatric population are high growth prospects for the sepsis diagnostics market during the forecast period.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=92673155
Browse in-depth TOC on "Sepsis Diagnostics Market"
167 - Tables
18 - Figures
266 - Pages
Sepsis Diagnostics Market Scope:
Report Coverage | Details |
Market Revenue in 2024 | $634 million |
Estimated Value by 2029 | $890 million |
Growth Rate | Poised to grow at a CAGR of 7.0% |
Market Size Available for | 2021-2029 |
Forecast Period | 2024-2029 |
Forecast Units | Value (USD Million) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered | Technology, Product, Method, Pathogen Type, Test Type, End user, and Region |
Geographies Covered | North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Report Highlights | Updated financial information / product portfolio of players |
Key Market Opportunities | Rapid diagnostic/POC techniques development for early sepsis diagnosis |
Key Market Drivers | Increasing hospital-acquired infection incidences |
The molecular diagnostics segment is to register a significant growth rate over the forecast period of 2024-2029.
Based on the technology, over the forecast period of 2024-2029, the molecular diagnostics segment is to register a significant growth rate. The sepsis diagnostics product market is segmented into blood culture, immunoassays, molecular diagnostics, flow cytometry, microfluidics, and biomarkers. The molecular diagnostics segment comprises PCR, microarray, peptide nucleic acid fluorescent in situ hybridization and DNA sequencing. The key factors encouraging the growth of mesh segment during the forecast period are the the growing need for early disease diagnosis and various advantages offered by this technique as compared others.
The hospitals & speciality clinics segment accounted for the largest share of sepsis diagnostics market in 2024-2029.
Based on end user, the hospitals & speciality clinics segment is estimated to hold the largest market share of the sepsis diagnostics market during the forecast period. Increasing number of patients hospitalized with sepsis, in-house hospital laboratories perform a large number of blood culture tests to identify the blood stream infections (BSIs caused by bacteria, fungi/yeast, or viruses) and high prevalence of sepsis coupled with a large number of fatalities caused by the illness lead to a large share of the segment.
Asia Pacific registered the highest CAGR in the market during the forecast period.
In 2024, Asia Pacific is expected to register the highest CAGR in the market for sepsis diagnostics during the forecast period. Asia Pacific comprises China, India, South Korea, Taiwan, and Singapore, and the rest of Asia Pacific. Factors such as the growing adoption of advanced treatment options, presence of a large target patient population and improving diagnosis and treatment rates are driving the growth of the APAC sepsis diagnostics market during the forecast period.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=92673155
Sepsis Diagnostics Market Dynamics:
Drivers:
- Increasing hospital-acquired infection incidences
Restraints:
- High costs of automated diagnostic devices
Opportunities:
- Rapid diagnostic/POC techniques development for early sepsis diagnosis
Challenge:
- Dearth of skilled healthcare professionals
Key Market Players of Sepsis Diagnostics Industry:
As of 2023, prominent players in sepsis diagnostics are bioMérieux (France), Becton Dickinson Company (US), Danaher Corporation (US), Abbott Laboratories (US), and Roche Diagnostics (Switzerland). Other players include T2 Biosystems (US), Thermo Fisher Scientific (US), Bruker (US), EKF Diagnostics (UK), Immunexpress (Australia), among others.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1- 25%, Tier 2- 30%, and Tier 3- 45%
- By Designation: C-level- 26%, Directors- 30%, and Others- 44%
- By Region: North America- 40%, Europe- 31%, Asia Pacific- 20%, Latin America- 6%, MEA- 3%
Recent Developments of Sepsis Diagnostics Industry:
- In April 2023, BioMérieux launched BIOFIRE FIREWORKS, an integrated software solution for BIOFIRE Systems optimizing laboratory services and supporting data-driven decisions.
- In May 2023, Sysmex Corporation launched clinical flow cytometry system Flow Cytometer XF-1600, Sample Preparation System PS-10, antibody reagents, and other related products in Japan.
- In June 2023, T2 Biosystems collaborated with Vanderbilt University Medical Center to implement and evaluate the T2Bacteria Panel for clinical use.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=92673155
Sepsis Diagnostics Market - Key Benefits of Buying the Report:
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their market presence.
This report provides insights on the following pointers:
- Analysis of key drivers (High incidence of sepsis, Rising incidence of hospital-acquired infections (HAIs), Growing funding for sepsis-related research), restraints (High cost of automated diagnostic devices), opportunities (Development of rapid diagnostic/POC techniques for early sepsis diagnosis, Evolution of novel biomarkers for sepsis diagnosis, Growth Opportunities in emerging economies), and challenges (Lack of awareness and limited protocols for sepsis diagnosis, Shortage of skilled healthcare professionals) influencing the growth of the sepsis diagnostics market
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the sepsis diagnostics market
- Service Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and service developments in the sepsis diagnostics market
- Market Development: Comprehensive information on lucrative emerging regions
- Market Diversification: Exhaustive information about new services, growing geographies, and recent developments in the sepsis diagnostics market
- Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and services of the leading market players.
Related Reports:
Transplant Diagnostics Market - Global Forecasts to 2028
Molecular Diagnostics Market - Global Forecasts to 2028
Blood Culture Tests Market- Global Forecasts to 2028
Point of Care Molecular Diagnostics Market - Global Forecasts to 2028
Point of Care Diagnostics Market - Global Forecasts to 2028
About MarketsandMarkets:
MarketsandMarkets has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Aashish Mehra
MarketsandMarkets INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insights: https://www.marketsandmarkets.com/ResearchInsight/sepsis-diagnostic-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/sepsis-diagnostic.asp
Logo - https://mma.prnewswire.com/media/2297424/MarketsandMarkets_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/sepsis-diagnostics-market-worth-890-million--marketsandmarkets-302110343.html
